Renal Business Today - dialysis, end-stage renal disease (ESRD), home dialysis, chronic kidney disease (CKD), nephrology, Medicare bundle, kidney, dialysis practice management, kidney disease patients

FEATURES

Essay Contest for Kidney Patients

GLENDALE, Calif.—The Renal Support Network (RSN), a nonprofit, patient-focused, patient-run organization that provides nonmedical services to those affected by chronic kidney disease (CKD), encourages people with kidney ...read more

Travel on Dialysis

“The world is a book, and those who do not travel read only one page,” said Augustine of Hippo. For many, travel provides an expanded world view and a great deal of joy. For many hemodialysis patients, travel seems ...read more

2013 RPA Meeting

If you missed the three-day, 2013 Renal Physician Association conference held in New Orleans, Renal Business Today was there and has the highlights available at your fingertips in the latest digital issue. Renal ...read more

Venous Needle Dislodgement

Venous needle dislodgement (VND) occurs when a venous needle dislodges from a patient's vascular access during hemodialysis treatment. This report discusses VND severity and presents best practices and other solutions to ...read more

A Recipe Guide to Lowering Salt Intake

Whether you are a kidney disease patient or a non-kidney patient, it is important to keep your kidneys as healthy as possible by following a low-sodium diet. Did you know that for a healthy individual over the age of 50, a ...read more

Latest Headlines

Lifeline Vascular Access partners with Open Access

MIAMI—Lifeline Vascular Access announced May 19 that it has partnered with Open Access to provide vascular access services for dialysis patients in the south Florida area. ...More
May 20, 2008
Posted in News, Business, Clinical & Pharma
African Americans with early-stage CKD have higher death risk than whites

LOS ANGELES—African-American patients with early stages of chronic kidney disease have a higher risk of death than white patients at the same stage of disease, according to a study to be published in July’s Journal of the American Society of Nephrology. ...More
May 19, 2008
Posted in News, Clinical & Pharma
APP Pharmaceuticals raises heparin prices

SCHAUMBURG, Ill.—APP Pharmaceuticals said today that it has raised its price of the blood-thinning drug heparin due to more product testing and the increase in cost of raw materials resulting from the discovery of contaminated heparin coming from China. ...More
May 15, 2008
Posted in News, Business, Clinical & Pharma, Government & Regulation
Bernard Charra to receive ISHD Belding Scribner Award

VICENZA, Italy—On June 3, the International Society for Hemodialysis will present Bernard Charra, MD, with the Belding Scribner ISHD Award. ...More
May 15, 2008
Posted in News, Business, Clinical & Pharma, Practice Management
Kidney patient advocates push education in Senate Medicare bill

NEW YORK—Kidney patient advocates plan to meet May 22 in WashingtonD.C. in hopes they can persuade lawmakers to add a provision to a Medicare bill that would include a pre-dialysis education benefit. ...More
May 15, 2008
Posted in News, Business, Government & Regulation
Hematide well tolerated in CKD patients

STOCKHOLM—Clinical data showed that the anemia drug Hematide given once a month was well-tolerated and maintain hemoglobin levels between 11 and 12 g/dL for one year in patients with chronic kidney disease on and not on dialysis, according to a presentation at the ...More
May 15, 2008
Posted in News, Business, Clinical & Pharma
FDA warns Shire about Fosrenol promotional materials

Shire Pharmaceuticals received a warning from federal regulators over a couple of marketing pieces for its phosphate binder drug Fosrenol.The U.S. Food and Drug Administration’s Division of Drug Marketing, Advertising and Communications (DDMAC) sent Shire a warning ...More
May 15, 2008
Posted in Blog
Just Getting to the Doctor Is Half the Battle

Just getting to the doctor's office is an exercise fraught with difficulty -- accessibility, driving issues, impaired vision, and other problems can create difficulty in simply getting out the door and to the appointment. ...More
May 9, 2008
Posted in News, Clinical & Pharma, Practice Management
Heparin costs double since recall

U.S. dialysis centers are paying nearly double what they’re used to for the blood-thinning drug heparin because of recalls and the contamination of raw ingredients in China, according to a report from USA Today.Click HERE to read the story.Dialysis providers Renal ...More
May 9, 2008
Posted in Blog
Medical research is essential to improving the economy and bettering lives

WASHINGTON— Healthcare in the United States is expensive, but its continued funding is necessary as it also is a major contributor to the economy and can better lives, according to an essay in the June issue of the Journal of the American Society Nephrology. ...More
May 8, 2008
Posted in News, Business, Clinical & Pharma, Government & Regulation